Sign In
Buy RMD
$188.63
+2.34 (+1.26%)
At Close: Jun 18, 2026
ResMed Earnings Reflect Increased Demand For Sleep Devices, Performance Indicates Positive Dynamics, Opportunities
10:46am, Friday, 02'nd Aug 2024
ResMed Inc. RMD reported fourth-quarter 2024 revenue of $1.22 billion, up 9% year-over-year and up 10% on a constant currency basis, in line with the consensus of $1.22 billion.
ResMed's (RMD) Q4 Earnings Surpass Estimates, Margins Expand
09:17am, Friday, 02'nd Aug 2024
ResMed (RMD) delivers solid performance across all regions and business segments in the fourth quarter of fiscal 2024.
Lost Money on ResMed Inc. (RMD)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
07:30am, Friday, 02'nd Aug 2024
NEW YORK, NY / ACCESSWIRE / August 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of ResMed Inc. ("ResMed") (NYSE:RMD) concerning possible violations of federal s
ResMed Inc. (RMD) Q4 2024 Earnings Call Transcript
10:58pm, Thursday, 01'st Aug 2024
ResMed Inc. (NYSE:RMD ) Q4 2024 Earnings Conference Call August 031, 2024, 04:30 PM ET Company Participants Amy Wakeham - Chief Communications and Investor Relations Officer Michael Farrell - Chief Ex
Compared to Estimates, ResMed (RMD) Q4 Earnings: A Look at Key Metrics
07:31pm, Thursday, 01'st Aug 2024
While the top- and bottom-line numbers for ResMed (RMD) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to W
ResMed (RMD) Beats Q4 Earnings and Revenue Estimates
06:15pm, Thursday, 01'st Aug 2024
ResMed (RMD) came out with quarterly earnings of $2.08 per share, beating the Zacks Consensus Estimate of $2.03 per share. This compares to earnings of $1.60 per share a year ago.
ResMed meets estimates on steady demand for its sleep apnea devices
04:43pm, Thursday, 01'st Aug 2024
Medical equipment maker ResMed reported fourth-quarter revenue in line with estimates on Thursday, on steady demand for its sleep apnea treatment devices.
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024
04:05pm, Thursday, 01'st Aug 2024
Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com
RMD ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of ResMed Inc. Shareholders Who Lost Money
07:30am, Thursday, 01'st Aug 2024
NEW YORK, NY / ACCESSWIRE / August 1, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of ResMed Inc. ("ResMed") (NYSE:RMD) concerning possible violations of federal s
Why ResMed (RMD) is Poised to Beat Earnings Estimates Again
01:10pm, Tuesday, 30'th Jul 2024
ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
09:50am, Tuesday, 30'th Jul 2024
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Levi & Korsinsky Reminds ResMed Investors of the Ongoing Investigation into Potential Violations of Securities Laws - RMD
07:30am, Tuesday, 30'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 30, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of ResMed Inc. ("ResMed") (NYSE:RMD) concerning possible violations of federal se
Seeking Clues to ResMed (RMD) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
10:21am, Monday, 29'th Jul 2024
Evaluate the expected performance of ResMed (RMD) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for b
Shareholders that lost money on ResMed Inc.(RMD) should contact Levi & Korsinsky about Securities Fraud Investigation - RMD
07:25am, Monday, 29'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of ResMed Inc. ("ResMed") (NYSE:RMD) concerning possible violations of federal se
NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of ResMed Inc. ("ResMed") (NYSE:RMD) concerning possible violations of federal se
